⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AMRX News
Amneal Pharmaceuticals, Inc. Class A Common Stock
Form 8-K
sec.gov
AMRX
Form 8-K
sec.gov
AMRX
Amneal Reports First Quarter 2026 Financial Results
globenewswire.com
AMRX
AMERX ADDS EQUITY RESEARCH FOR INSTITUTIONAL CLIENTS
prnewswire.com
AMRX
No Waitlists, No Pharmacies: AM Rx Brings Same-Day GLP-1 Weight Loss Consultations to Patients Nationwide
accessnewswire.com
AMRX
Form 8-K
sec.gov
AMRX
Amneal Agrees to Acquire Kashiv BioSciences to Create Global Biosimilar Leader; Reports Strong Preliminary First Quarter 2026 Financial Results and Raises FY2026 Standalone Guidance
globenewswire.com
AMRX
Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY®
globenewswire.com
AMRX
Amneal Launches First Two Respiratory Metered-Dose Inhalation Products in the U.S.
globenewswire.com
AMRX
Airway Therapeutics nombra a Joe Todisco miembro de su Consejo de Administración USA - español USA - Français USA - English
prnewswire.com
CRMD
AMRX
PRGS